Thursday, 27th April
Asia-Pacific Vaccine and Immunotherapy Congress 2023
Days
Wednesday, 26th April
Thursday, 27th April
Friday, 28th April
Search
Speakers
Session 5: Immune Cell Types and Biology
8:30AM - 10:30AM
Thursday, 27th April
Boulevard Auditorium
Chair: Katherine Kedzierska
Converting immune cells into anti-cancer agents
-
Dario Campana
Checkpoint inhibitors in inflammatory diseases
-
Fernando Guimaraes
Identifying Cellular Checkpoints in Inflammation and Cancer
-
Gabrielle Belz
Multiplexed single protein mapping of immune checkpoints
-
Ian Parish
Future of Cytometry: Who will Supervise the Single Cell Analysis?
-
Yann Abraham
Can We Tame The Immune Response to Treat Gastric Cancer Without Adverse Outcomes?
-
Lorraine A O'Reilly
Morning Tea & Networking
10:30AM - 11:00AM
Thursday, 27th April
Boulevard Foyer
Session 6: Vaccine Design & Delivery 1
11:00AM - 12:30PM
Thursday, 27th April
Boulevard Auditorium
Chairs: Ian Barr & Lisa Ng
Immunomonitoring of COVID-19 infection and vaccination
-
Laurent Renia
Characterizing antibody responses in SARS-CoV2 infection and Vaccination
-
Amy Chung
Development and Phase I trial of two novel SARS-CoV-2 beta variant receptor-binding domain recombinant protein and mRNA vaccines as 4
th
dose boosters – interim analysis
-
Terry Nolan
BCG::ESAT6-PE25SS – a new live attenuated tuberculosis vaccine candidate – results from pre-clinical evaluation
-
Andreas Kupz
A Synthetic Peptide Vaccine Based on the Conserved Region of the Streptococcal M-Protein and the IL-8 Protease, SpyCEP, Demonstrates Prophylactic and Therapeutic Efficacy Against Streptococcal Superficial and Invasive Infections
-
Manisha Pandey
A comparative characterization of SARS-CoV-2-specific T cells induced by mRNA or inactive virus COVID-19 vaccines
-
Joey Ming Er Lim
Lunch
12:30PM - 1:30PM
Thursday, 27th April
Boulevard Foyer
Session 7: Industry Showcase 2
1:30PM - 3:00PM
Thursday, 27th April
Boulevard Auditorium
Chairs: Corey Smith & Rebecca Lim
Machine-Learning to develop next-generation influenza vaccines
-
Saranya Sridhar
The Novavax investigational influenza vaccine, leading to the development of a COVID Influenza combination (CIC) vaccine
-
Vivek Shinde
Meaningful Innovation: Pfizer collaboration strategy in the Emerging Sciences
-
Anand Gautam
Opportunities & Challenges for Vaccination with Microarray Patches
-
Angus Forster
Next Generation Influenza Vaccines
-
Jules Bayliss
Microbiome based therapeutics in Melanoma
-
Trent Munro
Afternoon Tea & Networking
3:00PM - 3:30PM
Thursday, 27th April
Boulevard Foyer
Session 8: Immuno-Engineering
3:30PM - 5:15PM
Thursday, 27th April
Boulevard Auditorium
Chairs: Lorraine O'Reilly & Sudha Rao
Enhancing the persistence and metabolic fitness of CAR T cells for improved efficacy in solid tumours
-
Paul Beavis
Early immune pressure initiated by tissue-resident memory T cells sculpts tumour evolution in non-small cell lung cancer
-
Marie-Liesse Asselin-Labat
Gene-therapy based modulation of antigen-presenting cells within hyperproliferative epithelium to restore immunity
-
Thi Viet Trinh Dang
Engineering a TGF-β switch receptor enhances CAR-T cell function in a suppressive TGF-β-enriched tumor microenvironment
-
Vicky Qin
Investigating the tumour immune microenvironment of breast implant associated anaplastic large cell lymphoma using single cell RNA sequencing
-
Criselle DSouza
Identifying optimal gene promoters for CRISPR-HDR generated armoured CAR T cells
-
Kah Min Yap
Poster Session 2
5:15PM - 7:00PM
Thursday, 27th April
Boulevard Foyer
Amelioration of Chemotherapy-induced Immunosuppression for Amplifying Anti-tumor Immunity by Biomimetic Clay Platform
-
Jingjing Wang
Splenic marginal zone lymphoma can be prognostically stratified using three-dimensional analysis
-
Zoe West
Peripheral blood gene expression predicts progression to type-1 diabetes mellitus in autoantibody positive children through potentially modifiable pathways
-
Jia Yi Hee
Novel immunotherapeutics in the treatment of cancer in pet dogs: an investigation into the tumour microenvironment
-
Annika LM Oksa
Bioengineered polymer particulate vaccines for prevention of Chikungunya infection
-
Nivethika Sivakumaran
Utilising managed quarantine in Australia for influenza virus characterisation and vaccine strain selection
-
Heidi A Peck
Development of cyclic lipopeptide-based vaccine candidates against group A
Streptococcus
-
Jiahui Zhang
The double-edge sword of checkpoint inhibition: PD-1 expression in CD4
+
T cells is required to maintain peripheral tolerance to CD8
+
T cells.
-
Jeniffer Loaiza Naranjo
Molecular design of disulfide-rich peptides for immunotherapy
-
Conan Wang
Development and production of particulate vaccines against Hepatitis C virus infection
-
Anjali Kakkanat
Self-assembled particulate vaccines for the prevention of Q fever
-
Gayathri Sam
Elucidating the role of COX-2 and 5-LOX in head and neck cancer progression.
-
Gavin M Turrell
Novel immunotherapeutic approaches for the prevention of viral diseases in immunocompromised settings
-
Swathi Muralidhar
Aberrant immune cell number and function underpins increased mortality in respiratory viral infected bone marrow transplant recipients
-
Sophie C Hamann
Elevated IL-6 levels are associated with increased mortality upon respiratory infection after bone marrow transplantation
-
Antiopi Varelias
Faecal microbiota transfer reduces acute graft-versus-host disease via IgA and mucin secretion in the gastrointestinal tract
-
Antiopi Varelias
An
in vivo
model of human Hemophagocytic Lymphohistiocytosis
-
Liam J O'Brien
Functional genetic screens identify CTL evasion genes at breast cancer susceptibility loci
-
Wei Shi
Maternal high fat diet predisposes the infant to systemic chronic inflammation and lung disease through IL-6 trans-signaling
-
Tufael Mr Ahmed
Functional characterisation and transcriptomic analysis of antigen-specific CD8 T memory stem cells (T
SCM
) generated from clonally expanded single T
SCM
cells
in vitro
-
Yanran Zhao
Determining if Osteopontin is an immune checkpoint of
KRAS
mutant Colorectal Cancer
-
Bianca A Nowlan
Role of cytomegalovirus infection on the development of immunity to
Plasmodium falciparum
malaria
-
Reena Kiran Mukhiya
Using CRISPR activation applications to identify novel tumour resistance mechanisms of aggressive lymphomas in CAR-T cell therapy.
-
Christina Koenig
Modelling
S. pyogenes
infection of the URT to reveal mechanisms of site-specific and cross-compartment immunity and to support vaccine development
-
Ailin Lepletier
Glycolipidated-liposomal peptide-based vaccine induces protection against
Streptococcus pyogenes
upper respiratory tract infection.
-
Victoria Ozberk
Age-dependent differences in the composition of malaria antigen-specific CD4 T cells
-
Mayimuna Nalubega
Harnessing the Stress Response for Immunity in Acute Myeloid Leukaemia
-
Basit Salik
← Wednesday
Friday →